311 related articles for article (PubMed ID: 28592124)
1. Long non-coding RNA MALAT1 promotes cholangiocarcinoma cell proliferation and invasion by activating PI3K/Akt pathway.
Wang C; Mao ZP; Wang L; Wu GH; Zhang FH; Wang DY; Shi JL
Neoplasma; 2017; 64(5):725-731. PubMed ID: 28592124
[TBL] [Abstract][Full Text] [Related]
2. Protein tyrosine phosphatase PTP4A1 promotes proliferation and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma via the PI3K/AKT pathway.
Liu LZ; He YZ; Dong PP; Ma LJ; Wang ZC; Liu XY; Duan M; Yang LX; Shi JY; Zhou J; Fan J; Gao Q; Wang XY
Oncotarget; 2016 Nov; 7(46):75210-75220. PubMed ID: 27655691
[TBL] [Abstract][Full Text] [Related]
3. LncRNA MALAT1 promotes proliferation and metastasis in epithelial ovarian cancer via the PI3K-AKT pathway.
Jin Y; Feng SJ; Qiu S; Shao N; Zheng JH
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3176-3184. PubMed ID: 28770968
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA NNT-AS1 promotes cholangiocarcinoma cells proliferation and epithelial-to-mesenchymal transition through down-regulating miR-203.
Gu Y; Zhu Z; Pei H; Xu D; Jiang Y; Zhang L; Xiao L
Aging (Albany NY); 2020 Feb; 12(3):2333-2346. PubMed ID: 32019904
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of celastrol by inhibition of proliferation, invasion, and migration in cholangiocarcinoma via PTEN/PI3K/Akt pathway.
Zhu B; Wei Y
Cancer Med; 2020 Jan; 9(2):783-796. PubMed ID: 31957323
[TBL] [Abstract][Full Text] [Related]
6. MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway.
Dong Y; Liang G; Yuan B; Yang C; Gao R; Zhou X
Tumour Biol; 2015 Mar; 36(3):1477-86. PubMed ID: 25431257
[TBL] [Abstract][Full Text] [Related]
7. IRF4-induced upregulation of lncRNA SOX2-OT promotes cell proliferation and metastasis in cholangiocarcinoma by regulating SOX2 and PI3K/AKT signaling.
Wei CX; Wong H; Xu F; Liu Z; Ran L; Jiang RD
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8169-8178. PubMed ID: 30556855
[TBL] [Abstract][Full Text] [Related]
8. LncRNA MALAT1 affects high glucose-induced endothelial cell proliferation, apoptosis, migration and angiogenesis by regulating the PI3K/Akt signaling pathway.
Zhang SH; Zhang SG; Zhou P; Wei X; Mao XD; Lin SG; Liu C
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8551-8559. PubMed ID: 31646587
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
Gene; 2019 May; 698():50-60. PubMed ID: 30822475
[TBL] [Abstract][Full Text] [Related]
10. LncRNA MALAT1 expression inhibition suppresses tongue squamous cell carcinoma proliferation, migration and invasion by inactivating PI3K/Akt pathway and downregulating MMP-9 expression.
Yuan J; Xu XJ; Lin Y; Chen QY; Sun WJ; Tang L; Liang QX
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):198-206. PubMed ID: 30657561
[TBL] [Abstract][Full Text] [Related]
11. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
Tang Y; Xiao G; Chen Y; Deng Y
Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
[TBL] [Abstract][Full Text] [Related]
12. LncRNA MALAT1 Promotes Cancer Metastasis in Osteosarcoma via Activation of the PI3K-Akt Signaling Pathway.
Chen Y; Huang W; Sun W; Zheng B; Wang C; Luo Z; Wang J; Yan W
Cell Physiol Biochem; 2018; 51(3):1313-1326. PubMed ID: 30481748
[TBL] [Abstract][Full Text] [Related]
13. The long noncoding RNA MALAT1/microRNA-598-3p axis regulates the proliferation and apoptosis of retinoblastoma cells through the PI3K/AKT pathway.
Lin X; Huang X; Wang L; Liu W
Mol Vis; 2022; 28():269-279. PubMed ID: 36284668
[TBL] [Abstract][Full Text] [Related]
14. LncRNA MALAT1 regulates trophoblast cells migration and invasion via miR-206/IGF-1 axis.
Wu HY; Wang XH; Liu K; Zhang JL
Cell Cycle; 2020 Jan; 19(1):39-52. PubMed ID: 31774373
[TBL] [Abstract][Full Text] [Related]
15. Tip60 Suppresses Cholangiocarcinoma Proliferation and Metastasis via PI3k-AKT.
Zhang Y; Ji G; Han S; Shao Z; Lu Z; Huo L; Zhang J; Yang R; Feng Q; Shen H; Wang H; Li X
Cell Physiol Biochem; 2018; 50(2):612-628. PubMed ID: 30308494
[TBL] [Abstract][Full Text] [Related]
16. MALAT1 promotes cisplatin resistance in cervical cancer by activating the PI3K/AKT pathway.
Wang N; Hou MS; Zhan Y; Shen XB; Xue HY
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7653-7659. PubMed ID: 30536307
[TBL] [Abstract][Full Text] [Related]
17. Quercetin promotes the apoptosis of fibroblast-like synoviocytes in rheumatoid arthritis by upregulating lncRNA MALAT1.
Pan F; Zhu L; Lv H; Pei C
Int J Mol Med; 2016 Nov; 38(5):1507-1514. PubMed ID: 28026003
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851
[TBL] [Abstract][Full Text] [Related]
19. LncRNA DLEU2 silencing impedes the migration, invasion and EMT in gastric cancer cell by suppressing PI3K/AKT signaling pathway.
Hu J; Wang M; Yang Y; Xing Y; Li S
Immunopharmacol Immunotoxicol; 2022 Oct; 44(5):719-731. PubMed ID: 35736813
[No Abstract] [Full Text] [Related]
20. Tetraspanin 1 promotes epithelial-to-mesenchymal transition and metastasis of cholangiocarcinoma via PI3K/AKT signaling.
Wang Y; Liang Y; Yang G; Lan Y; Han J; Wang J; Yin D; Song R; Zheng T; Zhang S; Pan S; Liu X; Zhu M; Liu Y; Cui Y; Meng F; Zhang B; Liang S; Guo H; Liu Y; Hassan MK; Liu L
J Exp Clin Cancer Res; 2018 Dec; 37(1):300. PubMed ID: 30514341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]